Twenty-year survivorship of a cemented mobile bearing Total Knee Arthroplasty.


Journal

The Knee
ISSN: 1873-5800
Titre abrégé: Knee
Pays: Netherlands
ID NLM: 9430798

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 21 11 2018
revised: 14 05 2019
accepted: 01 06 2019
pubmed: 3 7 2019
medline: 14 11 2019
entrez: 3 7 2019
Statut: ppublish

Résumé

Increasing numbers of Total Knee Arthroplasty (TKA) operations are carried out worldwide each year. This brings with it an ever-increasing revision burden and it is therefore important to appreciate both the functional outcome and survivorship of established arthroplasties when considering new designs. We aim to evaluate the long-term survivorship of a fully cemented mobile bearing Total Knee Arthroplasty. This study prospectively analyses the 20-year survivorship of a cohort of 487 consecutive patients who underwent cemented TKA under the care of a single surgeon using the Low Contact Stress (LCS) rotating platform (RP) implant. These patients were followed up prospectively with patient reported and functional outcomes recorded at regular intervals postoperatively. Five hundred and forty-two consecutive primary TKAs were carried out in 487 patients. A total of 139 knees (25.6%) were reviewed at 20 years post-operation. Overall cumulative survivorship, using revision for any reason as primary endpoint, was 98.0%. Mean Knee Society Scores for the patient cohort were 87.3 (Clinical score) and 52.5 (Functional score). Eleven (2.0%) were revised within 20 years - two for aseptic loosening, two for unexplained pain, five secondary patellar resurfacings for anterior knee pain, one for late infection and one liner exchange following spin-out. This series demonstrates excellent survivorship and satisfactory outcome of a cemented mobile bearing TKA at 20 years.

Sections du résumé

BACKGROUND BACKGROUND
Increasing numbers of Total Knee Arthroplasty (TKA) operations are carried out worldwide each year. This brings with it an ever-increasing revision burden and it is therefore important to appreciate both the functional outcome and survivorship of established arthroplasties when considering new designs. We aim to evaluate the long-term survivorship of a fully cemented mobile bearing Total Knee Arthroplasty.
METHODS METHODS
This study prospectively analyses the 20-year survivorship of a cohort of 487 consecutive patients who underwent cemented TKA under the care of a single surgeon using the Low Contact Stress (LCS) rotating platform (RP) implant. These patients were followed up prospectively with patient reported and functional outcomes recorded at regular intervals postoperatively.
RESULTS RESULTS
Five hundred and forty-two consecutive primary TKAs were carried out in 487 patients. A total of 139 knees (25.6%) were reviewed at 20 years post-operation. Overall cumulative survivorship, using revision for any reason as primary endpoint, was 98.0%. Mean Knee Society Scores for the patient cohort were 87.3 (Clinical score) and 52.5 (Functional score). Eleven (2.0%) were revised within 20 years - two for aseptic loosening, two for unexplained pain, five secondary patellar resurfacings for anterior knee pain, one for late infection and one liner exchange following spin-out.
CONCLUSION CONCLUSIONS
This series demonstrates excellent survivorship and satisfactory outcome of a cemented mobile bearing TKA at 20 years.

Identifiants

pubmed: 31262634
pii: S0968-0160(19)30120-6
doi: 10.1016/j.knee.2019.06.004
pii:
doi:

Substances chimiques

Bone Cements 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

933-940

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

David J Milligan (DJ)

Outcomes Unit, Primary Joint Unit, Musgrave Park Hospital, Stockman's Lane, Belfast BT9 7JB, United Kingdom. Electronic address: davidmilligan@doctors.org.uk.

Seamus O'Brien (S)

Outcomes Unit, Primary Joint Unit, Musgrave Park Hospital, Stockman's Lane, Belfast BT9 7JB, United Kingdom.

Emer Doran (E)

Outcomes Unit, Primary Joint Unit, Musgrave Park Hospital, Stockman's Lane, Belfast BT9 7JB, United Kingdom.

Nicola E Gallagher (NE)

Outcomes Unit, Primary Joint Unit, Musgrave Park Hospital, Stockman's Lane, Belfast BT9 7JB, United Kingdom.

David E Beverland (DE)

Outcomes Unit, Primary Joint Unit, Musgrave Park Hospital, Stockman's Lane, Belfast BT9 7JB, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH